At Belenos Biosciences Inc., we believe that clinical remission should be the standard—not the exception—for treating chronic inflammatory diseases like COPD, asthma and atopic dermatitis. Our bispecific therapeutics are designed to target proven disease pathways, with the goal of delivering meaningful, lasting outcomes for patients. With a focus on innovation and speed, we are advancing our pipeline with urgency to bring next-generation treatments to those who need them most. An Orbimed company
Company Details
- Employees
- 8
- Founded
- 2024
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://Belenosbio.com
- Keywords
- Encinitas.
Belenos Biosciences Inc. Questions
Belenos Biosciences Inc.'s website is http://Belenosbio.com
Belenos Biosciences Inc.'s LinkedIn profile is https://www.linkedin.com/company/belenos-biosciences-inc
Belenos Biosciences Inc. has
8 employees.
View email and phone details for 8
employees at Belenos Biosciences Inc..
Belenos Biosciences Inc.'s industry is
Biotechnology Research
Belenos Biosciences Inc.'s top competitors are
Biohaven,
Danish-American Chamber Of Commerce,
California Department Of Toxic Substances Control,
Indaco Venture Partners,
Factspread,
Optinose,
Our World Too,
Context Therapeutics,
Elevaate Biotech,
Pinnacle Medicines.
Belenos Biosciences Inc.'s categories are Biotechnology Research
Belenos Biosciences Inc.'s founding year is 2024
